Mark Connolly

Field Reimbursement Director, Northeast at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Mark Connolly's Colleagues at Alnylam Pharmaceuticals
Keith Skrzypiec

Business Account Executive

Contact Keith Skrzypiec

Michael Drozd

Director, PV Science, Global Patient Safety & Risk Management

Contact Michael Drozd

Heather Swech

Senior Director, Global Patient Discovery and Engagement Center of Excellence

Contact Heather Swech

Steve Mussoline

Regional Business Director

Contact Steve Mussoline

Lisa Marcello

Business Account Executive

Contact Lisa Marcello

Allison Stogdale

Associate Director, Global Patient Safety & Risk Management

Contact Allison Stogdale

View All Mark Connolly's Colleagues
Mark Connolly's Contact Details
HQ
(617) 551-8200
Location
Erie, Pennsylvania Area
Company
Alnylam Pharmaceuticals
Mark Connolly's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Mark Connolly
Mark Connolly currently works for Alnylam Pharmaceuticals.
Mark Connolly's role at Alnylam Pharmaceuticals is Field Reimbursement Director, Northeast.
Mark Connolly's email address is ***@alnylam.com. To view Mark Connolly's full email address, please signup to ConnectPlex.
Mark Connolly works in the SaaS industry.
Mark Connolly's colleagues at Alnylam Pharmaceuticals are Keith Skrzypiec, Debi Tran, Michael Drozd, Heather Swech, Steve Mussoline, Lisa Marcello, Allison Stogdale and others.
Mark Connolly's phone number is (617) 551-8200
See more information about Mark Connolly